Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.


Aspirin, used at low doses (75-325 mg daily), prevents aggregation of platelets and is prescribed for patients as pharmacologic prevention of cardiovascular disease. Despite the well-documented beneficial effects of aspirin, prolonged use is associated with damage to the gastrointestinal (GI) mucosa in the upper and lower GI tract. Patient risk of… (More)
DOI: 10.3810/pgm.2014.01.2728


4 Figures and Tables

Slides referencing similar topics